These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 37213606)
1. Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities. Shi J; Chen X; Hu H; Ung COL Front Public Health; 2023; 11():1172557. PubMed ID: 37213606 [TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
4. Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications. Liang Z; Lai Y; Li M; Shi J; Lei CI; Hu H; Ung COL Chin Med; 2021 Feb; 16(1):23. PubMed ID: 33593397 [TBL] [Abstract][Full Text] [Related]
5. The evolving regulatory system of advanced therapy medicinal products in China: a documentary analysis using the World Health Organization Global Benchmarking Tool standards. Shi J; Chen X; Hu H; Ung COL Cytotherapy; 2024 Aug; 26(8):954-966. PubMed ID: 38739075 [TBL] [Abstract][Full Text] [Related]
6. Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model. Li M; Chen S; Lai Y; Liang Z; Wang J; Shi J; Lin H; Yao D; Hu H; Ung COL Front Med (Lausanne); 2021; 8():669509. PubMed ID: 34136505 [TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
8. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol. Newell S; Jordan Z JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009 [TBL] [Abstract][Full Text] [Related]
9. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
10. Implementation science in traditional, complementary and integrative medicine: An overview of experiences from China and the United States. Chung VC; Ho FF; Lao L; Liu J; Lee MS; Chan KW; Nilsen P Phytomedicine; 2023 Jan; 109():154591. PubMed ID: 36610171 [TBL] [Abstract][Full Text] [Related]
11. Risk management frameworks for human health and environmental risks. Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953 [TBL] [Abstract][Full Text] [Related]
12. Adopting recommendations for implementing patient involvement in cancer research: a funder's approach. Costa Alencar AB; Selig WKD; Geissler J; Bereczky T; Ubide A; Haerry D; Stephens R; Behan V Res Involv Engagem; 2023 Mar; 9(1):6. PubMed ID: 36859346 [TBL] [Abstract][Full Text] [Related]
13. [Drug regulatory authorities in South America: an analysis based on organizational rules]. Sandri MM; De Seta MH; Luiza VL Rev Panam Salud Publica; 2013 Sep; 34(3):169-75. PubMed ID: 24233109 [TBL] [Abstract][Full Text] [Related]
14. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
15. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related]
16. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020. Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836 [TBL] [Abstract][Full Text] [Related]
17. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
18. Critical Care Network in the State of Qatar. Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205 [TBL] [Abstract][Full Text] [Related]
19. Primary Care Research Team Assessment (PCRTA): development and evaluation. Carter YH; Shaw S; Macfarlane F Occas Pap R Coll Gen Pract; 2002 Feb; (81):iii-vi, 1-72. PubMed ID: 12049028 [TBL] [Abstract][Full Text] [Related]